{"id":14791,"date":"2024-04-16T11:49:54","date_gmt":"2024-04-16T11:49:54","guid":{"rendered":"http:\/\/TheNextWeb=1405771"},"modified":"2024-04-16T11:49:54","modified_gmt":"2024-04-16T11:49:54","slug":"french-software-firm-launches-biggest-ipo-on-eu-stock-exchange-in-3-years","status":"publish","type":"post","link":"https:\/\/www.londonchiropracter.com\/?p=14791","title":{"rendered":"French software firm launches biggest IPO on EU stock exchange in 3 years"},"content":{"rendered":"\n<div><img decoding=\"async\" src=\"https:\/\/img-cdn.tnwcdn.com\/image\/tnw-blurple?filter_last=1&amp;fit=1280%2C640&amp;url=https%3A%2F%2Fcdn0.tnwcdn.com%2Fwp-content%2Fblogs.dir%2F1%2Ffiles%2F2024%2F04%2FUntitled-design-55.jpg&amp;signature=7d8a954b60bd3a3cbda2732116485b18\" class=\"ff-og-image-inserted\"><\/div>\n<p>French SaaS company Planisware launched its initial public offering (IPO) today, reaching a valuation of \u20ac1.11bn. This is the largest IPO on the Euronext Paris stock exchange in the past three years.<\/p>\n<p>Planisware was founded in 1996 by Yves Humblot, Pierre Demonsant, Matthieu Delille, and <span>Fran\u00e7ois Pelissolo. <\/span>Planisware&nbsp;provides <a href=\"https:\/\/thenextweb.com\/topic\/software\" target=\"_blank\" rel=\"noopener\">software<\/a> for enterprise project portfolio management. It counts over 500 blue-chip clients across the globe, including PepsiCo and Pfizer, and employs circa 700 people.<\/p>\n<p>The company has seen its consolidated revenue grow at a compounded annual rate of approximately 20% during the last three years \u2014 with an EBITDA margin of over 33% in 2023.<\/p>\n<p>Planisware will offer a maximum of 15,085,00 ordinary shares to be sold for \u20ac241mn. The price per share is \u20ac16 and trading is expected to start on April 18, the company said.<\/p>\n<p>Following the IPO, the founders will retain both an active role in the company\u2019s leadership as well as a majority stake.<\/p>\n<div class=\"inarticle-wrapper channel-cta\">\n<div class=\"ica-text\" readability=\"0\"><a href=\"https:\/\/thenextweb.com\/conference\/tickets?utm_source=google&amp;utm_medium=display&amp;utm_campaign=global%7Ctnw_media%7Cevent_registration%7Cretargeting%7Coffer%7C2024_tnw_conference_amsterdam%7CTNW&amp;utm_content=2for1\" data-event-category=\"Article\" data-event-action=\"In Article Block\" data-event-label=\"TNW Conference 2024- 2for1 offer this week only!\" target=\"_blank\" readability=\"4\" rel=\"noopener\"><\/p>\n<p class=\"ica-text__title\">TNW Conference 2024- 2for1 offer this week only!<\/p>\n<p>Don&#8217;t miss out on the world-class speakers. Secure your 2for1 tickets before 23 April.<\/p>\n<p><\/a><\/div>\n<\/div>\n<p>The IPO represents an \u201cimportant step\u201d for Planisware\u2019s brand awareness, growth strategy, and plans for further global expansion, Pierre Demonsant, co-founder and chairman of the company, said in a statement.<\/p>\n<p>Planisware postponed an IPO attempt in October last year, <a href=\"https:\/\/www.reuters.com\/markets\/deals\/planisware-postpones-initial-public-offering-euronext-2023-10-11\/\" target=\"_blank\" rel=\"nofollow noopener\">citing<\/a> a challenging market environment, which <a href=\"https:\/\/www.ft.com\/content\/8ddfd5a1-4c7c-4427-9666-24d2befedfc2\" target=\"_blank\" rel=\"nofollow noopener\">halted multiple European companies<\/a> from pursuing public listings.<\/p>\n<p> <a href=\"https:\/\/thenextweb.com\/news\/software-firm-planisware-biggest-ipo-eu-stock-exchange-3-years\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>French SaaS company Planisware launched its initial public offering (IPO) today, reaching a valuation of \u20ac1.11bn. This is the largest IPO on the Euronext Paris stock exchange in the past three years&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":14792,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/14791"}],"collection":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=14791"}],"version-history":[{"count":0,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/posts\/14791\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=\/wp\/v2\/media\/14792"}],"wp:attachment":[{"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=14791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=14791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.londonchiropracter.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=14791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}